These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30916883)

  • 1. Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: Evolution, risk factors, and impact on patient outcomes.
    Defrancq C; De Wilde N; Raes A; Van Biervliet S; Vande Velde S; Van Winckel M; De Bruyne R; Prytuła A
    Pediatr Transplant; 2019 May; 23(3):e13388. PubMed ID: 30916883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High intra-patient variability of tacrolimus within post-operative 1 month predicted worse 1-year outcomes in pediatric liver transplant recipients.
    Chen F; Yong JK; Shen C; Zhou T; Feng M; Wan P; Luo Y; Lin H; Qian Y; Xia Q
    Eur J Clin Pharmacol; 2024 Jul; 80(7):1017-1027. PubMed ID: 38502358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus Intrapatient Variability on Graft Outcomes in Adherent Renal Transplantation Patients: A Cross-Sectional Study.
    Nafar M; Keshtkari S; Ziaie S; Firouzan A; Borumandnia N; Dalili N; Poorrezagholi F; Samadian F; Samavat S
    Iran J Kidney Dis; 2024 May; 18(3):187-194. PubMed ID: 38904339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High tacrolimus intra-patient variability is associated with graft rejection, and
    Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
    World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation.
    van der Veer MAA; Nangrahary N; Hesselink DA; Erler NS; Metselaar HJ; van Gelder T; Darwish Murad S
    Transplantation; 2019 Nov; 103(11):2329-2337. PubMed ID: 30801539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.
    Sablik KA; Clahsen-van Groningen MC; Hesselink DA; van Gelder T; Betjes MGH
    PLoS One; 2018; 13(5):e0196552. PubMed ID: 29746495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation.
    Xie W; Fan S; Liu R; Yan W; Su C; Zheng K; Wang X; Wang Z
    Transplant Rev (Orlando); 2024 Jul; 38(3):100842. PubMed ID: 38537484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
    Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes.
    Rayar M; Tron C; Jézéquel C; Beaurepaire JM; Petitcollin A; Houssel-Debry P; Camus C; Verdier MC; Dehlawi A; Lakéhal M; Desfourneaux V; Meunier B; Sulpice L; Bellissant E; Boudjema K; Lemaitre F
    Transplantation; 2018 Mar; 102(3):e108-e114. PubMed ID: 29315140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early post-operative intravenous tacrolimus in pediatric liver transplant recipients is not superior to oral tacrolimus.
    Sabra TA; Okajima H; Yoshizawa A; Ogawa E; Okamoto S; Osman MA; Saad-Eldin Y; Uemoto S
    Pediatr Transplant; 2019 May; 23(3):e13368. PubMed ID: 30719833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Tacrolimus Intrapatient Variability on Allograft Rejection Frequency and Survival Following Liver Transplantation.
    Soares ME; Costa G; Guerra L; Morais MC; Vaz N; Codes L; Bittencourt PL
    Ther Drug Monit; 2024 Aug; 46(4):456-459. PubMed ID: 38648652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients.
    Abu Bakar K; Mohamad NA; Hodi Z; McCulloch T; Williams A; Christian M; Key T; Kim JJ
    Pediatr Nephrol; 2019 Dec; 34(12):2557-2562. PubMed ID: 31520127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis.
    Kizilbash SJ; Rheault MN; Bangdiwala A; Matas A; Chinnakotla S; Chavers BM
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28371243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes.
    Mendoza Rojas A; Hesselink DA; van Besouw NM; Dieterich M; de Kuiper R; Baan CC; van Gelder T
    Ther Drug Monit; 2022 Jun; 44(3):369-376. PubMed ID: 35394988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation.
    Choi JS; Ko H; Kim HK; Chung C; Han A; Min SK; Ha J; Kang HG; Ha IS; Min S
    Pediatr Transplant; 2022 Sep; 26(6):e14297. PubMed ID: 35466485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients.
    Taber DJ; Hirsch J; Keys A; Su Z; McGillicuddy JW
    Ther Drug Monit; 2021 Jun; 43(3):401-407. PubMed ID: 33560095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation.
    Park Y; Lee H; Eum SH; Kim HD; Ko EJ; Yang CW; Chung BH
    Front Immunol; 2021; 12():746013. PubMed ID: 34659243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation.
    Park Y; Lee H; Eum SH; Ko EJ; Min JW; Yoon SH; Hwang WM; Yun SR; Yang CW; Shin J; Chung BH
    Front Immunol; 2022; 13():1037566. PubMed ID: 36466843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
    An S; Lee S; Rhu J; Kim JM; Choi GS; Joh JW
    J Pediatr Surg; 2023 Oct; 58(10):2054-2058. PubMed ID: 37277238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.